NEURALTUS PHARMACEUTICALS, INC.

Profile

Company Names

NEURALTUS PHARMACEUTICALS, INC.

Addresses

1001 BAYHILL DRIVE, SUITE 300, SAN BRUNO, CA 94066

2483 E. BAYSHORE ROAD, SUITE 212, PALO ALTO, CA 94303

1455 ADAMS DRIVE, SUITE 2030, MENLO PARK, CA 94025

Phone Numbers

(650) 424-1600
6504241600
(650) 279-7028

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2004

State Incorporated:

DE

Total Amount Raised:

$30,957,859.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2016-05-17 
$14,938,357.00 
$21,938,357.00 
$7,000,000.00 
Equity 
2
2011-12-15 
$11,125,649.00 
$11,125,649.00 
$0.00 
Equity 
1
2009-03-25 
$4,893,853.00 
$18,000,000.00 
$13,106,147.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ARI 
 
AZHIR 
EXECUTIVE OFFICER, DIRECTOR
NEURALTUS PHARMACEUTICALS, INC.   |  JAGUAR HEALTH, INC.   |  AQUYRE BIOSCIENCES INC
ANNETTE 
 
BIANCHI 
DIRECTOR
NEURALTUS PHARMACEUTICALS, INC.   |  KADMUS PHARMACEUTICALS INC   |  TARGEGEN INC   |  ALLOCADE INC
RICHARD 
 
CASEY 
EXECUTIVE OFFICER, DIRECTOR
NEURALTUS PHARMACEUTICALS, INC.
ANDREW 
 
GENGOS 
EXECUTIVE OFFICER, DIRECTOR
NEURALTUS PHARMACEUTICALS, INC.   |  CYTEIR THERAPEUTICS, INC.
TERRY 
 
GOULD 
DIRECTOR
NEURALTUS PHARMACEUTICALS, INC.   |  PROTEUS BIOMEDICAL INC   |  LIGHT SCIENCES ONCOLOGY INC   |  INCLINE THERAPEUTICS, INC.   |  NAUREX INC.   |  ONCOMED PHARMACEUTICALS INC   |  OUTPOST MEDICINE, LLC   |  ATOX BIO INC.   |  QPEX BIOPHARMA, INC.   |  ICOSAVAX, INC.
DONALD 
 
MCGOVERN 
DIRECTOR
NEURALTUS PHARMACEUTICALS, INC.
JOHN 
 
WALKER 
DIRECTOR
AFFYMAX INC   |  AEROVANCE INC   |  US GEOTHERMAL INC   |  IPIERIAN, INC.   |  FUSION MULTISYSTEMS INC   |  ENERVEST ENERGY INSTITUTIONAL FUND XII-A, L.P.   |  ENERVEST ENERGY INSTITUTIONAL FUND XII-B, L.P.   |  ENERVEST ENERGY INSTITUTIONAL FUND XII-C, L.P.   |  ENERVEST ENERGY INSTITUTIONAL CO-INVESTMENT FUND XII-1C, L.P.   |  ENERVEST ENERGY INSTITUTIONAL CO-INVESTMENT XII-1A, L.P.   |  ZENPH SOUND INNOVATIONS INC   |  HAMILTON STATE BANCSHARES INC   |  NEURALTUS PHARMACEUTICALS, INC.   |  ENERVEST ENERGY INSTITUTIONAL CO-INVESTMENT XII-2A, L.P.   |  CYPHER, LLC   |  ALDEA PHARMACEUTICALS, INC.   |  ENERVEST ENERGY INSTITUTIONAL FUND XIV-1A, L.P.   |  PHYSICIANS SENIOR CARE FUND, LLC   |  ENERVEST ENERGY INSTITUTIONAL FUND XIV-3A, L.P.   |  ZOSANO PHARMA CORP   |  BEP LEGACY A, LLC   |  BEP LEGACY C, LLC   |  BEP LEGACY 1C, LLC   |  BEP LEGACY 2A, LLC   |  MIAMI SURGERY CENTER, LLC   |  VPC PARTNERS XVI LLC   |  OVATION.IO, INC.   |  ORTHOPEDIC SURGERY CENTER OF PALM BEACH COUNTY, LLC   |  IPAYED, LLC   |  COLONIAL OUTPATIENT SURGERY CENTER, LLC   |  TRAILS EDGE SURGERY CENTER, LLC   |  ROOTS PRODUCTIONS, LLC   |  PARZIVAL ENERGY, LLC   |  OV IV, L.P.   |  REVIVEHEALTH, INC.   |  KOIOS MEDICAL, INC.   |  SURGICAL CENTER OF THE TREASURE COAST, L.L.C.   |  ATHLETIC BREWING HOLDING COMPANY, LLC
JOHN 
 
WHELAN 
EXECUTIVE OFFICER
AP PHARMA INC /DE/   |  NEURALTUS PHARMACEUTICALS, INC.
JAMES 
 
WOODY 
DIRECTOR
CELL BIOSCIENCES INC   |  TETRALOGIC PHARMACEUTICALS CORP   |  NEURALTUS PHARMACEUTICALS, INC.   |  HEMAQUEST PHARMACEUTICALS, INC.   |  PERCEPTIMED, INC.   |  VIRACTA THERAPEUTICS, INC.
JAMES 
N. 
WOODY 
DIRECTOR
NEURALTUS PHARMACEUTICALS, INC.   |  HEMAQUEST PHARMACEUTICALS   |  180 LIFE SCIENCES CORP.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2016-05-24
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-05-17 
2012-05-31
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-12-15 
2011-12-20
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-12-15 
2009-04-07
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-03-25 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#